We are live on
!
Find out more
AGC
Alden Global Capital Portfolio holdings
AUM
$177M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
-25.21%
1 Year Est. Return
+32.31%
3 Year Est. Return
+79.81%
5 Year Est. Return
+211.53%
10 Year Est. Return
+43.32%
AUM
$153M
AUM Growth
-$139M
(-48%)
Cap. Flow
-$83.4M
Cap. Flow
% of AUM
-54.36%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
13
New
1
Increased
1
Reduced
1
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
STON
StoneMor Inc.
STON
|
+$3.24M |
| 2 |
PRKR
Parkervision Inc
PRKR
|
+$1.06M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PIR
Pier 1 Imports, Inc.
PIR
|
+$65.2M |
| 2 |
OSG
Octave Specialty Group
OSG
|
+$9.08M |
| 3 |
International Seaways
INSW
|
+$5.06M |
| 4 |
Pacira BioSciences
PCRX
|
+$1.98M |
| 5 |
MTL
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
|
+$1.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.03% |
| 2 | Utilities | 1.68% |
| 3 | Technology | 1.42% |
| 4 | Energy | 0% |
| 5 | Healthcare | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRED
1
DELISTED
Fred's Inc
FRED
| $122M | 79.22% |
9,275,000
| – | – |
|
|
OSG
2
Octave Specialty Group
OSG
$253M
| $24.6M | 16.03% |
1,303,450
-431,700
| -25% | -$9.08M |
|
3
CEMIG Preferred Shares
CIG
$6.21B
| $2.57M | 1.68% |
1,532,166
| – | – |
|
|
STON
4
DELISTED
StoneMor Inc.
STON
| $2.54M | 1.66% |
+320,300
| New | +$3.24M |
|
|
PRKR
5
DELISTED
Parkervision Inc
PRKR
| $2.17M | 1.42% |
1,092,633
+500,000
| +84% | +$1.06M |
|
6
Acadia Healthcare
ACHC
$3.14B
| – | – |
-56,900
| Closed | -$1.88M |
|
7
Heron Therapeutics
HRTX
$85.3M
| – | – |
-65,935
| Closed | -$864K |
|
|
8
International Seaways
INSW
$4.52B
| – | – |
-360,334
| Closed | -$5.06M |
|
9
Novavax
NVAX
$1.27B
| – | – |
-32,025
| Closed | -$807K |
|
|
10
Pacira BioSciences
PCRX
$1.03B
| – | – |
-61,287
| Closed | -$1.98M |
|
|
XLRN
11
DELISTED
Acceleron Pharma
XLRN
| – | – |
-33,700
| Closed | -$860K |
|
|
PIR
12
DELISTED
Pier 1 Imports, Inc.
PIR
| – | – |
-381,602
| Closed | -$65.2M |
|
|
MTL
13
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| – | – |
-342,805
| Closed | -$1.96M |
|
Similar funds
CPL
CTC
ACM
WFL
ES
ACM
HHCP
SL
Alden Global Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Alden Global Capital held 13 positions worth $153M, down 48% from $293M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Alden Global Capital withdrew a net $83.4M in Q1 2017, closing 8 positions and reducing 1 holding. Its most notable exit was Pier 1 Imports, Inc., an estimated $65.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 13% a quarter earlier, followed by Utilities and Technology.
Against the trend, Alden Global Capital opened a new position in StoneMor Inc. worth $2.54M.
- Alden Global Capital's largest Q1 2017 buy was StoneMor Inc.: 320,300 shares worth $2.54M.
- Alden Global Capital added most to Parkervision Inc in Q1 2017, an estimated $1.06M increase.
- Alden Global Capital's biggest Q1 2017 reduction was Octave Specialty Group, cutting an estimated $9.08M.
- Alden Global Capital fully exited Pier 1 Imports, Inc. in Q1 2017, selling an estimated $65.2M.
- Alden Global Capital's ten largest holdings make up 100% of its $153M portfolio in Q1 2017.
- Alden Global Capital opened 1 new position and closed 8 in Q1 2017.
- Alden Global Capital's portfolio value fell 48% quarter-over-quarter to $153M.
Based on Alden Global Capital's 13F filing for Q1 2017, filed 11 May 2017.